Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a cancerous tumour in the head or neck area that has not spread to other parts of the body
- People whose doctors have determined that high-dose radiation treatment is appropriate for them, either as their main treatment or after surgery to remove the tumour
Who may not be able to join:
- People whose general health and ability to carry out daily activities is significantly limited (confirm with trial site)
- People who already have a skin rash, open sore, or wound in the area that would be treated
- People who are known to be allergic to trolamine (a common ingredient in some skin creams) or Prussian blue (a type of dye sometimes used in medicine)
- People who have an inflammatory or connective tissue condition affecting the skin, such as lupus or similar disorders
- People who have previously received radiation treatment to the head or neck area
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xingchen Peng, Sichuan University West China Hospital
Phone: +86 18980606753
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of grade 3 radiation dermatitis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.